PhageLab

A tailor-made zootechnical additive based on bacteriophage technology capable of inhibiting the growth of E. coli strains associated with avian colibacillosis, as well as helping to enhance the effectiveness of antibiotic therapy in specific geographic territories.

INSPEKTOR is a comprehensive technology that combines precision diagnostics, tailored bacteriophage therapy, and field support to control Salmonella spp. at the source.

PhageLab attended the 16th Goiano Poultry Symposium in Goiânia, Brazil, to discuss industry trends.

PhageLab published a study in *Scientific Reports* (Nature Portfolio) on...

PhageLab shares research results at the International Poultry Scientific Forum, part of IPPE.

PhageLab presents talks at the Southern Brazil Poultry Symposium on phages and artificial intelligence for health management.

PhageLab integrates sustainability into its strategy to ensure long-term business success, regulatory compliance, and operational resilience.

The company invites inquiries and visits, responding promptly to messages.

PhageLab Chile SpA prioritizes privacy and confidentiality, committing to protect personal data and respect user privacy.

Record time development of tailor-made solutions to control bacterial outbreaks in the livestock and poultry industries.

PhageLab Brasil Serviços de Análises Laboratoriais Ltda. values trust from clients, employees, suppliers, and partners.

PhageLab secures €100,000 in The Yield Lab’s investor-backed competition focused on dairy sustainability. The award highlights the company’s innovations in addressing environmental challenges within the dairy industry. PhageLab’s solution targets efficiency improvements and sustainable practices for dairy producers.

Oct 2024AgNavigatorNews article

PhageLab secures $11M in Series A funding to combat antibiotic-resistant bacteria. The company leverages phage therapy—a biological approach—to target and neutralize drug-resistant bacterial strains. This funding supports research and development of precision treatments for infections increasingly resistant to conventional antibiotics.

Feb 2024TechCrunchNews article

PhageLab secures $11 million in funding to develop phage-based treatments for bacterial infections in livestock. The company will use the capital to advance its pipeline of phage therapies targeting outbreaks in animal agriculture. Phage-based solutions leverage natural viruses to combat bacterial pathogens without antibiotics.

Jan 2024FeedstuffsNews article

Chilean biochemists adapt SARS-CoV-2 detection methods to identify disease-causing bacteria in livestock. The team leverages rapid testing techniques originally developed for COVID-19 to monitor antimicrobial-resistant pathogens. This shift supports early intervention in agricultural settings, addressing growing concerns over superbugs in farm animals.

Jul 2023ForbesNews article